Hybrid Conferencee

International Conference on Oncology, Molecular Biology and Cancer Therapeutics (ICOMBCT - 27)

1st - 2nd June 2027 | Manchester, UK
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 1–2 June 2027
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 5 SDGs SDGs 3, 4, 9, 10 and 16
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

1 JUN 2027 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Advancements in Precision Medicine
    34
    Track Overview

    This track will explore the latest developments in precision medicine as it relates to oncology. Emphasis will be placed on personalized treatment strategies that enhance patient outcomes through tailored therapeutic approaches.

    Track 02
    Molecular Mechanisms in Cancer Biology
    39
    Track Overview

    Focusing on the intricate molecular pathways involved in cancer biology, this track aims to elucidate the genetic and epigenetic factors that contribute to tumorigenesis. Presentations will highlight recent discoveries that inform our understanding of cancer progression.

    Track 03
    Innovations in Cancer Therapeutics
    39
    Track Overview

    This session will showcase groundbreaking therapeutic strategies in the treatment of various cancers. Participants will discuss novel drug formulations, delivery systems, and combination therapies that are reshaping oncology.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Tumor Microenvironment and Immune Response
    316
    Track Overview

    This track will delve into the complex interactions between tumors and their microenvironment, particularly focusing on immune evasion mechanisms. Research presented will highlight how these interactions can be targeted for therapeutic benefit.

    Track 05
    Biomarkers in Cancer Diagnosis and Prognosis
    39
    Track Overview

    The identification and validation of biomarkers are crucial for improving cancer diagnosis and prognosis. This session will cover the latest research on biomarkers that can predict treatment response and disease outcomes.

    Track 06
    Translational Oncology: Bridging Research and Practice
    39
    Track Overview

    This track will emphasize the translation of laboratory findings into clinical applications in oncology. Discussions will center around successful case studies and the challenges faced in implementing research into practice.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
View Day 02 Schedule →
Day 02

Keynote, Technical Sessions & Awards

2 JUN 2027 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Immunotherapy: Current Trends and Future Directions
    316
    Track Overview

    Focusing on the evolving field of immunotherapy, this session will address current trends, challenges, and future directions in harnessing the immune system to combat cancer. Presentations will include novel agents and combination strategies.

    Track 08
    Targeted Therapies in Oncology
    39
    Track Overview

    This track will explore the development and application of targeted therapies in the treatment of cancer. Emphasis will be placed on the mechanisms of action, resistance, and clinical outcomes associated with these therapies.

    Track 09
    Cancer Epidemiology and Prevention
    310
    Track Overview

    This session will focus on the epidemiological aspects of cancer, including risk factors, prevention strategies, and public health initiatives. Research presented will aim to inform policy and practice in cancer prevention.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Emerging Technologies in Cancer Research
    39
    Track Overview

    This track will highlight innovative technologies that are transforming cancer research, including genomics, proteomics, and bioinformatics. Participants will discuss how these technologies can enhance our understanding of cancer biology.

    Track 11
    Ethical Considerations in Cancer Research and Treatment
    310
    Track Overview

    This session will address the ethical implications of cancer research and treatment, including patient consent, access to therapies, and the role of equity in healthcare. Discussions will aim to foster a responsible approach to oncology practices.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
← Back to Day 01 Schedule
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure 10 Reduced Inequalities 16 Peace, Justice and Strong Institutions

Be Part of ICOMBCT-27

Submit your research or complete your conference registration.

Submit Abstract / Paper Complete Registration
Copyrights © . All Rights Reserved. Terms & Conditions